News
10 hours ago
License out/in
10 hours ago
Acquisition
Financing
20 hours ago
TRYNGOLZA™ (olezarsen) approved in the EU for severe hypertriglyceridemia (sHTG)
Drug ApprovalLicense out/in
20 hours ago
AcquisitionLicense out/in
Zealand Pharma announces EU approval of Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome
Clinical ResultDrug ApprovalOrphan Drug
17 Nov 2026
FDA OKs third renal indication for Roche's Gazyva, this time primary membranous nephropathy
Clinical ResultDrug ApprovalPriority ReviewBreakthrough Therapy
17 Nov 2026
AstraZeneca's next-gen C5 inhibitor Klygefa approved in US, EU for gMG
Clinical ResultDrug Approval
14 Nov 2026
New Drug Application Submission Completed for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer
NDADrug ApprovalClinical Result
13 Nov 2026
Regeneron's NPR1-blocking antibody baloncibart scores Phase II win in POTS
Clinical Result